In 2014, a number of local Chinese diagnostic reagent
companies (including BSBE, Maker Biotechnology, Health BioMed, Wondfo, Thalys)
intend to step in the capital market through IPO because they are optimistic
about the prospects of the diagnostic reagent industry; the raised funds will
be used in the expansion of the existing projects or the construction of new
projects. SHINVA, Humanwell Healthcare and Zhongyuan Union Stem Cell
Bioengineering have entered the diagnostic reagent industry through
acquisitions.
Chinese in
vitro diagnostic reagent market consists of biochemical diagnostic reagents,
immunodiagnostic reagents and molecular diagnostic reagents. Among them, the
immune reagents and biochemical reagents account for a relatively higher
combined proportion, such as around 65% in 2013.
Currently,
about 40%-50% share of the Chinese in vitro diagnostics market has been
dominated by foreign companies represented by Roche, Siemens, Abbott and
Johnson & Johnson. Although there are 300-400 local enterprises in China in
vitro diagnostics industry, the top ten Chinese companies which rank by
production scale only seize 30% market share, reflecting a low industry
concentration degree.
With the accelerated aging of the Chinese population, the
increase of personal health expenditure as well as the improved medical care
facilities and government health care system, China diagnostic reagent industry
has been developing quickly, especially in vitro diagnostic reagents occupy
over 90%. In 2013, Chinese in vitro diagnostics market size reached RMB22.98
billion, of which RMB16.61 billion came from in vitro diagnostic reagents.
Mindray Medical, KHB, Fosun Pharmaceutical, Maker
Biotechnology and Da An Gene act as giants in China in vitro diagnostics
industry. Especially, Mindray Medical and KHB achieved the respective in vitro
diagnostics revenue of RMB2.0458 billion and RMB1.0572 billion in 2013,
accounting for 13.5% of the total jointly.
The Report covers the following points:
·
Status
quo of China diagnostic reagent industry, including overview, market structure,
import, export, competition pattern and so on.
·
Development
environments and trends of China diagnostic reagent industry, embracing macro economy,
medical situation, and relevant policies.
·
Operation
and diagnostic reagent business of 17 major companies in China diagnostic
reagent industry.
Purchase a Copy of this
Report @ http://www.chinamarketresearchreports.com/contacts/purchase.php?name=114875
.
Table of Contents
1 Overview of Diagnostic Reagent Industry
1.1 Definition
1.2 Classification
1.3 Industry Chain
1.1 Definition
1.2 Classification
1.3 Industry Chain
2 Status Quo of China Diagnostic Reagent Industry
2.1 Overview
2.2 Market Structure
2.3 Import and Export
2.3.1 Import
2.3.2 Export
2.4 Competition Pattern
2.5 Market Segments
2.1 Overview
2.2 Market Structure
2.3 Import and Export
2.3.1 Import
2.3.2 Export
2.4 Competition Pattern
2.5 Market Segments
3 Development Environments and Trends of China Diagnostic
Reagent Industry
3.1 Positive Factors
3.1.1 Macro economy
3.1.2 Medical Care
3.1.3 Policies
3.2 Trends
3.2.1 Biochemical Immunodiagnostics is still the Mainstream
3.2.2 High Industrial Concentration Degree
3.2.3 Integrated Enterprises will See Better Development
3.1 Positive Factors
3.1.1 Macro economy
3.1.2 Medical Care
3.1.3 Policies
3.2 Trends
3.2.1 Biochemical Immunodiagnostics is still the Mainstream
3.2.2 High Industrial Concentration Degree
3.2.3 Integrated Enterprises will See Better Development
Explore All Market Intelligence Research Reports on Life Sciences & For Further Information Contact
sales@chinamarketresearchreports.com .
